Celldex Therapeutics Inc (CLDX) — Long-term Investment Intensity
Celldex Therapeutics Inc (CLDX) has a Long-term Investment Intensity of 1.2% as of December 2018. Long-term investments of $1.80 Million represent 1.2% of total assets of $155.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Celldex Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Celldex Therapeutics Inc Long-term Investment Intensity (2017–2018)
This chart shows how Celldex Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of December 2018, the intensity stands at 1.2%, reflecting long-term investments of $1.80 Million against total assets of $155.81 Million USD. Explore Celldex Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Celldex Therapeutics Inc (2017–2018)
The table below presents the year-by-year Long-term Investment Intensity for Celldex Therapeutics Inc from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Celldex Therapeutics Inc market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.2% | $1.80 Million | $155.81 Million | ▲ +0.6 pp |
| 2017 | 0.6% | $1.80 Million | $315.62 Million | — |